NEW YORK, Aug. 20 – Paradigm Genetics has developed a microarray for the rice pathogen Magnaporthe grisea, the company said on Monday.

The chip, which was developed for Paradigm by Agilent Technologies, comprises a host of Magnaporthe gene sequences and positive and negative controls to help in data analysis, Paradigm said.

Data on the microarray will be incorporated into Paradigm’s existing database of fungal organisms, which may be used to help discover and develop products against fungi.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.